Critical comparison of elastography methods to assess chronic liver disease

Nature Reviews Gastroenterology and Hepatology

Volumn 13, Issue 7, 2016, Pages 402-411

  Friedrich Rust, Mireen ^a   Poynard, Thierry ^b,c   Castera, Laurent ^d,e  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d BEAUJON HOSPITAL   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC LIVER DISEASE; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; ELASTOGRAPH; ELASTOGRAPHY; ESOPHAGUS VARICES; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER FIBROSIS; MAGNETIC RESONANCE ELASTOGRAPHY; NON INVASIVE PROCEDURE; PATIENT CARE; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SHEAR WAVE ELASTOGRAPHY; STAGING; SURVIVAL; ALGORITHM; CHRONIC DISEASE; DIAGNOSTIC IMAGING; ESOPHAGEAL AND GASTRIC VARICES; LIVER DISEASE; META ANALYSIS; PHYSIOLOGY; PRACTICE GUIDELINE; PROCEDURES; SENSITIVITY AND SPECIFICITY; SPLEEN; STANDARDS;

ALGORITHMS; CHRONIC DISEASE; ELASTICITY IMAGING TECHNIQUES; ESOPHAGEAL AND GASTRIC VARICES; HUMANS; LIVER DISEASES; PRACTICE GUIDELINES AS TOPIC; PRACTICE PATTERNS, PHYSICIANS'; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SPLEEN;

EID: 84976313484     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2016.86     Document Type: Review

References (134)

1. European Association for Study of Liver, & Asociacion LatinoAmericana para el Estudio del Higado. EASL-ALEH clinical practice guidelines: non-invasive tests for evaluation of liver disease severity and prognosis. J. Hepatol. 63, 237-264 (2015
2. European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatitis C virus infection. J. Hepatol. 60, 392-420 (2014
3. Cosgrove, D., et al. EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 2: clinical applications. Ultraschall Med. 34, 238-253 (2013
4. Ferraioli, G., et al. WFUMB guidelines and recommendations for clinical use of ultrasound elastography: part 3: liver. Ultrasound Med. Biol. 41, 1161-1179 (2015
5. Poynard, T., et al. Biomarkers of liver fibrosis. Adv. Clin. Chem. 46, 131-160 (2008
6. Boursier, J., et al. An extension of STARD statements for reporting diagnostic accuracy studies on liver fibrosis tests: the Liver-FibroSTARD standards. J. Hepatol. 62, 807-815 (2015
7. Houot, M., Ngo, Y., Munteanu, M., Marque, S., & Poynard, T. Systematic review with meta-analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and B. Aliment. Pharmacol. Ther. 43, 16-29 (2016
8. Bedossa, P., Dargere, D., & Paradise, V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38, 1449-1457 (2003
9. Poynard, T., et al. Liver biopsy analysis has a low level of performance for diagnosis of intermediate stages of fibrosis. Clin. Gastroenterol. Hepatol. 10, 657-663.e7 (2012
10. Mehta, S. H., Lau, B., Afdhal, N. H., & Thomas, D. L. Exceeding the limits of liver histology markers. J. Hepatol. 50, 36-41 (2009
11. Poynard, T., et al. FibroTest and Fibroscan performances revisited in patients with chronic hepatitis C. Impact of the spectrum effect and the applicability rate. Clin. Res. Hepatol. Gastroenterol. 35, 720-730 (2011
12. Castera, L. Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology 142, 1293-1302.e4 (2012
13. Poynard, T., et al. Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages. Clin. Chem. 53, 1615-1622 (2007
14. Lambert, J., et al. How to measure the diagnostic accuracy of noninvasive liver fibrosis indices: the area under the ROC curve revisited. Clin. Chem. 54, 1372-1378 (2008
15. Poynard, T., et al. Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTestTM) and transient elastography (FibroScan®). J. Hepatol. 60, 706-714 (2014
16. Poynard, T., et al. Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®). J. Hepatol. 61, 994-1003 (2014
17. Poynard, T., et al. Liver fibrosis evaluation using real time shear wave elastography: applicability and diagnostic performance using methods without a gold standard. J. Hepatol. 58, 928-935 (2013
18. Obuchowski, N. A. Estimating and comparing diagnostic tests? accuracy when the gold standard is not binary. Acad. Radiol. 12, 1198-1204 (2005
19. Watson, P. F., & Petrie, A. Method agreement analysis: a review of correct methodology. Theriogenology 73, 1167-1179 (2010
20. Degos, F., et al. Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study). J. Hepatol. 53, 1013-1021 (2010
21. Sandrin, L., et al. Transient elastography: a new non invasive method for assessment of hepatic fibrosis. Ultrasound Med. Biol. 29, 1705-1713 (2003
22. Friedrich-Rust, M., et al. Performance of transient elastography for the staging of liver fibrosis: a meta analysis. Gastroenterology 134, 960-974 (2008
23. Stebbing, J., et al. A meta-analysis of transient elastography for the detection of hepatic fibrosis. J. Clin. Gastroenterol. 44, 214-219 (2010
24. Talwalkar, J. A., Kurtz, D. M., Schoenleber, S. J., West, C. P., & Montori, V. M. Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 5, 1214-1220 (2007
25. Shaheen, A. A., Wan, A. F., & Myers, R. P. FibroTest and FibroScan for the prediction of hepatitis C related fibrosis: a systematic review of diagnostic test accuracy. Am. J. Gastroenterol. 102, 2589-2600 (2007
26. Chon, Y. E., et al. Performance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B: a meta-analysis. PLoS ONE 7, e44930 (2012
27. Boursier, J., et al. Determination of reliability criteria for liver stiffness evaluation by transient elastography. Hepatology 57, 1182-1191 (2013
28. Toshima, T., et al. New method for assessing liver fibrosis based on acoustic radiation force impulse: a special reference to the difference between right and left liver. J. Gastroenterol. 46, 705-711 (2011
29. Sporea, I., et al. Acoustic radiation force impulse elastography as compared to transient elastography and liver biopsy in patients with chronic hepatopathies. Ultraschall Med. 32, S46-S52 (2011
30. Bamber, J., et al. EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 1: basic principles and technology. Ultraschall Med. 34, 169-184 (2013
31. Barr, R. G., et al. WFUMB guidelines and recommendations for clinical use of ultrasound elastography: part 2: breast. Ultrasound Med. Biol. 41, 1148-1160 (2015
32. Barr, R. G., et al. Elastography assessment of liver fibrosis: Society of Radiologists in Ultrasound Consensus Conference Statement. Radiology 276, 845-861 (2015
33. Ophir, J., Cespedes, I., Ponnekanti, H., Yazdi, Y., & Li, X. Elastography: a quantitative method for imaging the elasticity of biological tissues. Ultrason. Imaging 13, 111-134 (1991
34. Friedrich-Rust, M., et al. Real-time elastography for noninvasive assessment of liver fibrosis in chronic viral hepatitis. AJR Am. J. Roentgenol. 188, 758-764 (2007
35. Yoshimitsu, K., et al. MR elastography of the liver at 3.0 T in diagnosing liver fibrosis grades; preliminary clinical experience. Eur. Radiol. 26, 656-663 (2016
36. Huwart, L., et al. Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to platelet ratio index. Radiology 245, 458-466 (2007
37. Huwart, L., et al. Liver fibrosis: non-invasive assessment with MR elastography. NMR Biomed. 19, 173-179 (2006
38. Godfrey, E. M., et al. A comparison of MR elastography and (31)P MR spectroscopy with histological staging of liver fibrosis. Eur. Radiol. 22, 2790-2797 (2012
39. Huwart, L., et al. Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology 135, 299-302 (2008
40. Hudson, J. M., Milot, L., Parry, C., Williams, R., & Burns, P. N. Inter-and intra-operator reliability and repeatability of shear wave elastography in the liver: a study in healthy volunteers. Ultrasound Med. Biol. 39, 950-955 (2013
41. Bota, S., et al. Intra-and interoperator reproducibility of acoustic radiation force impulse (ARFI) elastography - preliminary results. Ultrasound Med. Biol. 38, 1103-1108 (2012
42. Boursier, J., et al. Acoustic radiation force impulse: a new ultrasonographic technology for the widespread noninvasive diagnosis of liver fibrosis. Eur. J. Gastroenterol. Hepatol. 22, 1074-1084 (2010
43. D'Onofrio, M., Gallotti, A., & Mucelli, R. P. Tissue quantification with acoustic radiation force impulse imaging: measurement repeatability and normal values in the healthy liver. AJR Am. J. Roentgenol. 195, 132-136 (2010
44. Boursier, J., et al. Reproducibility of liver stiffness measurement by ultrasonographic elastometry. Clin. Gastroenterol. Hepatol. 6, 1263-1269 (2008
45. Fraquelli, M., et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 56, 968-973 (2007
46. Nascimbeni, F., et al. Significant variations in elastometry measurements made within short term in patients with chronic liver diseases. Clin. Gastroenterol. Hepatol. 13, 763-771.e6 (2015
47. Perazzo, H., et al. Interobserver variability in transient elastography analysis of patients with chronic hepatitis C. Liver Int. 35, 1533-1539 (2015
48. Roca, B., Resino, E., Torres, V., Herrero, E., & Penades, M. Interobserver discrepancy in liver fibrosis using transient elastography. J. Viral Hepat. 19, 711-715 (2012
49. Neukam, K., et al. Interobserver concordance in the assessment of liver fibrosis in HIV/HCV-coinfected patients using transient elastometry. Eur. J. Gastroenterol. Hepatol. 22, 801-807 (2010
50. Castera, L., et al. Pitfalls of liver stiffness measurement: a 5 year prospective study of 13,369 examinations. Hepatology 51, 828-835 (2010
51. Myers, R. P., et al. Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology 55, 199-208 (2012
52. Arena, U., et al. Liver stiffness is influenced by a standardized meal in patients with chronic hepatitis C virus at different stages of fibrotic evolution. Hepatology 58, 65-72 (2013
53. Fraquelli, M., et al. Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C. J. Hepatol. 54, 621-628 (2011
54. Coco, B., et al. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J. Viral Hepat. 14, 360-369 (2007
55. Millonig, G., et al. Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology 48, 1718-1723 (2008
56. Arena, U., et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 47, 380-384 (2008
57. Millonig, G., et al. Liver stiffness is directly influenced by central venous pressure. J. Hepatol. 52, 206-210 (2010
58. Mueller, S., et al. Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis. World J. Gastroenterol. 16, 966-972 (2010
59. Chen, Y. P., et al. Improving transient elastography performance for detecting hepatitis B cirrhosis. Dig. Liver Dis. 44, 61-66 (2012
60. Aube, C., et al. Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis. J. Hepatol. 30, 471-478 (1999
61. Colli, A., et al. Severe liver fibrosis or cirrhosis: accuracy of US for detection - analysis of 300 cases. Radiology 227, 89-94 (2003
62. Tsochatzis, E. A., et al. Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta analysis of diagnostic accuracy. J. Hepatol. 54, 650-659 (2011
63. Friedrich-Rust, M., et al. Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta-analysis. J. Viral Hepat. 19, e212-e219 (2012
64. Nierhoff, J., Chavez Ortiz, A. A., Herrmann, E., Zeuzem, S., & Friedrich-Rust, M. The efficiency of acoustic radiation force impulse imaging for the staging of liver fibrosis: a meta-analysis. Eur. Radiol. 23, 3040-3053 (2013
65. Bota, S., et al. Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis. Liver Int. 33, 1138-1147 (2013
66. Sporea, I., Bota, S., Gradinaru-Tascau, O., Sirli, R., & Popescu, A. Comparative study between two point Shear Wave Elastographic techniques: Acoustic Radiation Force Impulse (ARFI) elastography and ElastPQ. Med. Ultrason. 16, 309-314 (2014
67. Leung, V. Y., et al. Quantitative elastography of liver fibrosis and spleen stiffness in chronic hepatitis B carriers: comparison of shear-wave elastography and transient elastography with liver biopsy correlation. Radiology 269, 910-918 (2013
68. Ferraioli, G., et al. Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: A pilot study. Hepatology 56, 2125-2133 (2012
69. Herrmann, E., et al. 2D shear wave elastography is equivalent or superior to transient elastography for liver fibrosis assessment: results from an individual patient data based meta-analysis. J. Hepatol. 62, S199-S200 (2015
70. Cassinotto, C., et al. Non-invasive assessment of liver fibrosis with impulse elastography: comparison of Supersonic Shear Imaging with ARFI and FibroScan®. J. Hepatol. 61, 550-557 (2014
71. Gerber, L., et al. Assessment of liver fibrosis with 2D shear wave elastography in comparison to transient elastography and acoustic radiation force impulse imaging in patients with chronic liver disease. Ultrasound Med. Biol. 41, 2350-2359 (2015
72. Friedrich-Rust, M., et al. Real-time tissue elastography versus FibroScan for noninvasive assessment of liver fibrosis in chronic liver disease. Ultraschall Med. 30, 478-484 (2009
73. Koizumi, Y., et al. Liver fibrosis in patients with chronic hepatitis C: noninvasive diagnosis by means of real time tissue elastography - establishment of the method for measurement. Radiology 258, 610-617 (2011
74. Ferraioli, G., et al. Performance of real-time strain elastography, transient elastography, and aspartate-to platelet ratio index in the assessment of fibrosis in chronic hepatitis C. AJR Am. J. Roentgenol. 199, 19-25 (2012
75. Ochi, H., et al. Real-time tissue elastography for evaluation of hepatic fibrosis and portal hypertension in nonalcoholic fatty liver diseases. Hepatology 56, 1271-1278 (2012
76. Wu, T., et al. Accuracy of real-time tissue elastography for the evaluation of hepatic fibrosis in patients with chronic hepatitis B: a prospective multicenter study. Dig. Dis. 32, 791-799 (2014
77. Wang, Q. B., Zhu, H., Liu, H. L., & Zhang, B. Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: a meta-analysis. Hepatology 56, 239-247 (2012
78. Singh, S., et al. Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. Clin. Gastroenterol. Hepatol. 13, 440-451.e6 (2015
79. Bohte, A. E., et al. Non-invasive evaluation of liver fibrosis: a comparison of ultrasound-based transient elastography and MR elastography in patients with viral hepatitis B and C. Eur. Radiol. 24, 638-648 (2014
80. Ichikawa, S., et al. Comparison of the diagnostic accuracies of magnetic resonance elastography and transient elastography for hepatic fibrosis. Magn. Reson. Imaging 33, 26-30 (2015
81. AASLD/IDSA HCV Guidance Panel. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Hepatology 62, 932-954 (2015
82. Poynard, T., et al. Impact of pegylated interferon alfa 2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 122, 1303-1313 (2002
83. D'Ambrosio, R., et al. The diagnostic accuracy of Fibroscan for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response. J. Hepatol. 59, 251-256 (2013
84. Shiratori, Y., et al. Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy. Ann. Intern. Med. 132, 517-524 (2000
85. World Health Organization. Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection (WHO, 2015
86. de Franchis, R. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J. Hepatol. 63, 743-752 (2015
87. Tsochatzis, E. A., et al. Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis C. Hepatology 60, 832-843 (2014
88. Crossan, C., et al. Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation. Health Technol. Assess. 19, 9 (2015
89. Tapper, E. B., Sengupta, N., Hunink, M. G. M., Afdhal, N. H., & Lai, M. Cost-effective evaluation of nonalcoholic fatty liver disease with NAFLD fibrosis score and vibration controlled transient elastography. Am. J. Gastroenterol. 110, 1298-1304 (2015
90. Canavan, C., Eisenburg, J., Meng, L., Corey, K., & Hur, C. Ultrasound elastography for fibrosis surveillance is cost effective in patients with chronic hepatitis C virus in the UK. Dig. Dis. Sci. 58, 2691-2704 (2013
91. Foucher, J., et al. Diagnosis of cirrhosis by transient elastography (Fibroscan): a prospective study. Gut 55, 403-408 (2006
92. Shi, K. Q., et al. Transient elastography: a meta-analysis of diagnostic accuracy in evaluation of portal hypertension in chronic liver disease. Liver Int. 33, 62-71 (2013
93. Vizzutti, F., et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 45, 1290-1297 (2007
94. Colecchia, A., et al. Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis. Gastroenterology 143, 646-654 (2012
95. Bureau, C., et al. Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Aliment. Pharmacol. Ther. 27, 1261-1268 (2008
96. Lemoine, M., et al. Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis. Aliment. Pharmacol. Ther. 28, 1102-1110 (2008
97. Sánchez-Conde, M., et al. Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers. J. Viral Hepat. 17, 280-286 (2010
98. Llop, E., et al. Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumors. J. Hepatol. 56, 103-108 (2012
99. Reiberger, T., et al. Noninvasive screening for liver fibrosis and portal hypertension by transient elastography - a large single center experience. Wien. Klin. Wochenschr. 124, 395-402 (2012
100. Kitson, M. T., et al. Liver stiffness and the prediction of clinically significant portal hypertension and portal hypertensive complications. Scand. J. Gastroenterol. 50, 462-469 (2015
101. Kim, B. K., et al. A liver stiffness measurement-based, noninvasive prediction model for high-risk esophageal varices in B viral liver cirrhosis. Am. J. Gastroenterol. 105, 1382-1390 (2010
102. Berzigotti, A., et al. Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis. Gastroenterology 144, 102-111.e1 (2013
103. Castera, L., Pinzani, M., & Bosch, J. Non invasive evaluation of portal hypertension using transient elastography. J. Hepatol. 56, 696-703 (2012
104. Sharma, P., et al. Spleen stiffness in patients with cirrhosis in predicting esophageal varices. Am. J. Gastroenterol. 108, 1101-1107 (2013
105. Stefanescu, H., et al. Spleen stiffness measurement using Fibroscan for the noninvasive assessment of esophageal varices in liver cirrhosis patients. J. Gastroenterol. Hepatol. 26, 164-170 (2011
106. Elkrief, L., et al. Prospective comparison of spleen and liver stiffness by using shear-wave and transient elastography for detection of portal hypertension in cirrhosis. Radiology 275, 589-598 (2015
107. Takuma, Y., et al. Measurement of spleen stiffness by acoustic radiation force impulse imaging identifies cirrhotic patients with esophageal varices. Gastroenterology 144, 92-101 (2013
108. Colecchia, A., et al. Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study. J. Hepatol. 60, 1158-1164 (2014
109. Masuzaki, R., et al. Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography. Hepatology 49, 1954-1961 (2009
110. Akima, T., Tamano, M., & Hiraishi, H. Liver stiffness measured by transient elastography is a predictor of hepatocellular carcinoma development in viral hepatitis. Hepatol. Res. 41, 965-970 (2011
111. Jung, K. S., et al. Risk assessment of hepatitis B virus related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). Hepatology 53, 885-894 (2011
112. Fung, J., Lai, C. L., Seto, W. K., Wong, D. K. H., & Yuen, M. F. Prognostic significance of liver stiffness for hepatocellular carcinoma and mortality in HBeAg negative chronic hepatitis B. J. Viral Hepat. 18, 738-744 (2011
113. Robic, M. A., et al. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study. J. Hepatol. 55, 1017-1024 (2011
114. Chon, Y. E., et al. The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B. J. Clin. Gastroenterol. 46, 518-525 (2012
115. Kim, S. U., et al. Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis. PLoS ONE 7, e36676 (2012
116. Klibansky, D. A., et al. Transient elastography for predicting clinical outcomes in patients with chronic liver disease. J. Viral Hepat. 19, e184-193 (2012
117. Kim, D. Y., et al. Transient elastography-based risk estimation of hepatitis B virus-related occurrence of hepatocellular carcinoma: development and validation of a predictive model. Onco. Targets Ther. 6, 1463-1469 (2013
118. Wang, H. M., et al. Liver stiffness measurement as an alternative to fibrotic stage in risk assessment of hepatocellular carcinoma incidence for chronic hepatitis C patients. Liver Int. 33, 756-761 (2013
119. Narita, Y., et al. Prediction of liver stiffness hepatocellular carcinoma in chronic hepatitis C patients on interferon-based anti-viral therapy. J. Gastroenterol. Hepatol. 29, 137-143 (2014
120. Feier, D., Lupsor Platon, M., Stefanescu, H., & Badea, R. Transient elastography for the detection of hepatocellular carcinoma in viral C liver cirrhosis. Is there something else than increased liver stiffness? J. Gastrointestin. Liver Dis. 22, 283-289 (2013
121. Wong, G. L. H., et al. Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B. J. Hepatol. 60, 339-345 (2014
122. Vergniol, J., et al. Noninvasive tests for fibrosis and liver stiffness predict 5 year outcomes of patients with chronic hepatitis C. Gastroenterology 140, 1970-1979 (2011
123. de Ledinghen V., et al. Non-invasive tests for fibrosis and liver stiffness predict 5 year survival of patients chronically infected with hepatitis B virus. Aliment. Pharmacol. Ther. 37, 979-988 (2013
124. Corpechot, C., et al. Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis. Gastroenterology 146, 970-979.e6 (2014
125. Pang, J. X. Q., et al. Liver stiffness by transient elastography predicts liver-related complications and mortality in patients with chronic liver disease. PLoS ONE 9, e95776 (2014
126. Vergniol, J., et al. The evolution of non-invasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis C. Hepatology 60, 65-76 (2014
127. Merchante, N., et al. Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis. Hepatology 56, 228-238 (2012
128. Macías, J., et al. Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patients. AIDS 27, 2541-2549 (2013
129. Park, M. S., et al. Prognostic value of the combined use of transient elastography and fibrotest in patients with chronic hepatitis B. Liver Int. 35, 455-462 (2015
130. Pérez-Latorre, L., et al. Prediction of liver complications in patients with hepatitis C virus-related cirrhosis with and without HIV coinfection: comparison of hepatic venous pressure gradient and transient elastography. Clin. Infect. Dis. 58, 713-718 (2014
131. Wong, G. L. H., et al. Noninvasive assessments of liver fibrosis with transient elastography and Hui index predict survival in patients with chronic hepatitis B. J. Gastroenterol. Hepatol. 30, 582-590 (2015
132. Asrani, S. K., et al. Role of magnetic resonance elastography in compensated and decompensated liver disease. J. Hepatol. 60, 934-939 (2014
133. Cassinotto, C., et al. Liver and spleen elastography using supersonic shear imaging for the non-invasive diagnosis of cirrhosis severity and oesophageal varices. Dig. Liver Dis. 47, 695-701 (2015
134. Vermehren, J., et al. Comparison of acoustic radiation force impulse imaging with transient elastography for the detection of complications in patients with cirrhosis. Liver Int. 32, 852-858 (2012